We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Drug Industry Daily is the only electronic briefing that delivers coverage of developments at the FDA, FTC, HHS and other key agencies and decision-making bodies that affect the pharmaceutical industry around the world.
Each issue highlights the top issues affecting the industry including:
Patent exclusivity
Market globalization enforcement
EU pharmacovigilance
New inspection trends
Advertising practices
CAPA warning letters
Recalls
Drug Approvals
And more
Plus in every issue, subscribers receive the additional benefit of links to exclusive documents that support each article, such as draft and final guidances, 483s and warning letters, proposed rules, closeout letters, full text of proposed legislation and GAO reports.
Our 100% Money-Back Guarantee
There’s absolutely no risk to you. You get our 100% Money-Back Guarantee: If at any time, for any reason, you become dissatisfied with Drug Industry Daily, you may cancel your subscription and receive a full refund. No questions asked.
So, why wait? Become a subscriber to Drug Industry Daily today. It couldn’t be easier.
Daily, 250 issues/year, Electronic delivery.
$1,695 $847
Bonus
Subscribe to Drug Industry Daily and save 50% off the regular one-year price of $1,695
Key Benefits
LINKS TO KEY DOCUMENTS — You get links to key documents that support DID's articles such as draft and final guidances, 483s and warning letters, proposed rules, closeout letter, full text of proposed legislation and GAO reports.
ONLINE ACCESS — Consider our newsletter archive your personal library! Search your current issue — and hundreds of past issues — by keyword and relevancy.